News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Conference News EuroPCR 2023 MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact Caitlin E. Cox May 19, 2023
News Conference News EuroPCR 2023 Transcatheter MV Replacement vs Best Medical Therapy? Some Clues Shelley Wood May 17, 2023
News Conference News EuroPCR 2023 Registry Data Support TAVI in AS Patients With Cardiogenic Shock Caitlin E. Cox May 16, 2023
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Better Durability With Self-Expanding TAVI? Clues From UK TAVI Shelley Wood May 18, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Opinion Editor's Corner EuroPCR 2022 EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect Shelley Wood May 12, 2022
News Conference News EuroPCR 2021 Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry Todd Neale May 20, 2021
News Conference News EuroPCR 2020 ‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry Yael L. Maxwell July 01, 2020
News Conference News EuroPCR 2019 Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact Caitlin E. Cox June 07, 2019
News Conference News EuroPCR 2019 Allegra TAVR System Feasible for Treating Degenerated Surgical Valves Michael O'Riordan May 29, 2019
News Conference News EuroPCR 2019 Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE Michael O'Riordan May 24, 2019
News Conference News EuroPCR 2019 TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out Caitlin E. Cox May 24, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017